Literature DB >> 16980658

Expression of granulysin in polymyositis and inclusion-body myositis.

K Ikezoe1, S Ohshima, M Osoegawa, M Tanaka, K Ogawa, K Nagata, J-i Kira.   

Abstract

BACKGROUND: Granulysin, a recently defined cytolytic molecule, is expressed in cytotoxic T cells and natural killer cells in a similar way to perforin, which is reported to have a major role in the pathogenesis of polymyositis and inclusion-body myositis (IBM).
OBJECTIVE: To clarify the role of granulysin in polymyositis and IBM.
METHODS: The expression of granulysin and perforin was examined by double staining with CD8, CD4 and CD56 in endomysial infiltrating cells and autoinvasive cells in muscle biopsy specimens of 17 patients with polymyositis (6 steroid resistant and 11 steroid responsive) and of 7 patients with IBM.
RESULTS: Similar to perforin, granulysin was expressed in CD8, CD4 or CD56 cells in patients with polymyositis and IBM. The ratio of cells double positive for granulysin and CD8 to all CD8 cells at endomysial sites was notably higher in steroid-resistant polymyositis than in steroid-responsive polymyositis and IBM.
CONCLUSION: Granulysin expression in CD8 cells seems to be correlated with steroid resistance in polymyositis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16980658      PMCID: PMC2077550          DOI: 10.1136/jnnp.2005.081810

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  21 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

Review 2.  Granulysin, a new human cytolytic granule-associated protein with possible involvement in cell-mediated cytotoxicity.

Authors:  S V Peña; A M Krensky
Journal:  Semin Immunol       Date:  1997-04       Impact factor: 11.130

3.  Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice.

Authors:  D Kägi; B Ledermann; K Bürki; P Seiler; B Odermatt; K J Olsen; E R Podack; R M Zinkernagel; H Hengartner
Journal:  Nature       Date:  1994-05-05       Impact factor: 49.962

4.  Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis.

Authors:  N Goebels; D Michaelis; M Engelhardt; S Huber; A Bender; D Pongratz; M A Johnson; H Wekerle; J Tschopp; D Jenne; R Hohlfeld
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

5.  Inflammatory and non-inflammatory inclusion body myositis. Characterization of the mononuclear cells and expression of the immunoreactive class I major histocompatibility complex product.

Authors:  D Figarella-Branger; J F Pellissier; N Bianco; B Devictor; M Toga
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

6.  Granulysin-induced apoptosis. I. Involvement of at least two distinct pathways.

Authors:  S Gamen; D A Hanson; A Kaspar; J Naval; A M Krensky; A Anel
Journal:  J Immunol       Date:  1998-08-15       Impact factor: 5.422

7.  NK cells use perforin rather than granulysin for anticryptococcal activity.

Authors:  Ling Ling Ma; Christopher L C Wang; Graham G Neely; Slava Epelman; Alan M Krensky; Christopher H Mody
Journal:  J Immunol       Date:  2004-09-01       Impact factor: 5.422

8.  Immunohistochemical analysis of perforin and granzyme A in inflammatory myopathies.

Authors:  S Orimo; R Koga; K Goto; K Nakamura; M Arai; M Tamaki; H Sugita; I Nonaka; K Arahata
Journal:  Neuromuscul Disord       Date:  1994-05       Impact factor: 4.296

Review 9.  Sporadic inclusion-body myositis and hereditary inclusion-body myopathies: current concepts of diagnosis and pathogenesis.

Authors:  V Askanas; W K Engel
Journal:  Curr Opin Rheumatol       Date:  1998-11       Impact factor: 5.006

10.  Analysis of T cell receptor repertoire of muscle-infiltrating T lymphocytes in polymyositis. Restricted V alpha/beta rearrangements may indicate antigen-driven selection.

Authors:  R Mantegazza; F Andreetta; P Bernasconi; F Baggi; J R Oksenberg; O Simoncini; M Mora; F Cornelio; L Steinman
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

View more
  10 in total

1.  Predicting steroid response in muscle disease.

Authors:  N Nirmalananthan; M G Hanna
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-10       Impact factor: 10.154

Review 2.  Advances in the immunobiology and treatment of inflammatory myopathies.

Authors:  Marinos C Dalakas
Journal:  Curr Rheumatol Rep       Date:  2007-08       Impact factor: 4.592

3.  The inflammatory milieu in idiopathic inflammatory myositis.

Authors:  Ann M Reed; Floranne Ernste
Journal:  Curr Rheumatol Rep       Date:  2009-08       Impact factor: 4.592

Review 4.  Targeted immunotherapy trials for idiopathic inflammatory myopathies.

Authors:  Joerg-Patrick Stübgen
Journal:  J Neurol       Date:  2012-06-30       Impact factor: 4.849

5.  Granulysin activates antigen-presenting cells through TLR4 and acts as an immune alarmin.

Authors:  Poonam Tewary; De Yang; Gonzalo de la Rosa; Yana Li; Michael W Finn; Alan M Krensky; Carol Clayberger; Joost J Oppenheim
Journal:  Blood       Date:  2010-07-21       Impact factor: 22.113

Review 6.  Immunotherapies for Immune-Mediated Myopathies: A Current Perspective.

Authors:  Merrilee Needham; Frank L Mastaglia
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

Review 7.  Immune mechanisms in the pathogenesis of idiopathic inflammatory myopathies.

Authors:  Cecilia Grundtman; Vivianne Malmström; Ingrid E Lundberg
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

Review 8.  Immune and myodegenerative pathomechanisms in inclusion body myositis.

Authors:  Christian W Keller; Jens Schmidt; Jan D Lünemann
Journal:  Ann Clin Transl Neurol       Date:  2017-05-16       Impact factor: 4.511

9.  Single-Cell Transcriptomics Reveals Peripheral Immune Responses in Anti-Synthetase Syndrome-Associated Interstitial Lung Disease.

Authors:  Lili Zhu; Zhong Cao; Shiyao Wang; Changshui Zhang; Lei Fang; Yanhong Ren; Bingbing Xie; Jing Geng; Sheng Xie; Ling Zhao; Li Ma; Huaping Dai; Chen Wang
Journal:  Front Immunol       Date:  2022-02-17       Impact factor: 7.561

10.  Case Report: Elevated CPK, an indicator of idiopathic inflammatory myopathy?

Authors:  Hina N Khan; Usman Jilani; Shitij Arora
Journal:  F1000Res       Date:  2016-02-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.